Terms of Service
ElyChat Terms of Service
Effective Date: September 24, 2026
Last Updated: October 30, 2026
These Terms of Service (the “Terms”) are a binding agreement between you and Elytron Biotech Corporation (“Elytron,” “we,” “us,” or “our”) governing your access to and use of ElyChat, including its website, software, conversational interface, bioinformatics pipelines, sequence-processing tools, models, APIs, outputs, and related services (collectively, the “Service”).
By creating an account, clicking to accept these Terms, or accessing or using the Service, you agree to these Terms, our Privacy Policy, our Acceptable Use Policy, and our AI & Bioinformatics Disclaimer, each incorporated into these Terms by reference. If you do not agree, do not use the Service.
If you use the Service on behalf of a company, university, laboratory, or other organization, you represent that you have authority to bind that organization to these Terms. In that case, “you” includes that organization.
1. Eligibility and Accounts
You must be at least 18 years old and legally capable of entering into a binding agreement to use ElyChat.
You are responsible for maintaining the confidentiality of your account credentials and for all activity occurring through your account. You must provide accurate account information and promptly notify us at elychat@elytronbiotech.com if you believe your account has been compromised.
You may not share credentials in a manner that circumvents account, usage, or subscription restrictions.
2. Purpose of ElyChat
ElyChat is a computational research and information tool designed to process and analyze non-human bacterial and fungal biological sequence data and to allow users to interact conversationally with computational analyses of that data.
ElyChat is not a clinical, medical, diagnostic, veterinary, regulatory, legal, patent, biosafety, or professional advisory service. It is not a substitute for qualified professional review, experimentally validated methods, or independent verification.
3. Permitted Sequence Data; No Human Sequence Data
The Service is intended only for bacterial and fungal sequence data.
You must not upload:
- human genomic, transcriptomic, exomic, epigenomic, or other human sequence data;
- sequence data intentionally derived from human subjects;
- files known to contain human reads or human-identifiable sequence content unless such content has first been removed using an appropriate validated process;
- sequence data that you are not legally authorized to upload, analyze, or provide to Elytron; or
- content that violates the Acceptable Use Policy.
You are solely responsible for determining whether your data satisfies these requirements before uploading it.
Elytron may suspend processing, restrict access, or remove content that it reasonably believes violates these Terms.
4. User Content and Your Rights
“User Content” means files, FASTA files, nucleotide or amino-acid sequences, assemblies, annotations, metadata, prompts, messages, documents, feedback, and other information that you submit to or through the Service.
As between you and Elytron, you retain any ownership rights you may have in your User Content. Uploading User Content does not transfer ownership of the original User Content to Elytron.
You represent and warrant that:
- you own the User Content or have all rights, permissions, licenses, and authorizations necessary to provide it to Elytron;
- your submission and Elytron’s permitted use of the User Content will not violate any contract, confidentiality obligation, intellectual-property right, trade-secret right, law, regulation, permit, biological-resource access requirement, or third-party right; and
- the User Content complies with these Terms and the Acceptable Use Policy.
You must not upload third-party confidential information, proprietary strain information, unpublished sequence data, trade secrets, or other restricted material unless you are authorized to grant Elytron the rights described in these Terms.
5. License and Data Use Rights Granted to Elytron
By submitting User Content to the Service, you grant Elytron a worldwide, non-exclusive, royalty-free license to host, store, copy, transmit, reproduce, process, transform, analyze, annotate, index, compare, and otherwise use the User Content only as necessary to provide, operate, maintain, secure, monitor, and support the Service to you. "User Content" includes your uploaded sequence data, prompts, conversations, analyses, and Outputs.
What Elytron Never Does With User Content (All Plans)
On every plan, Elytron will not:
- use or reproduce the content of your User Content, including sequences, annotations of your genomes, prompts, conversation text, and Outputs, in any publication, presentation, marketing material, dataset, database, or reference resource;
- sell, rent, disclose, or share your User Content with third parties, other than service providers that process it on Elytron's behalf solely to deliver the Service;
- use your User Content to develop or improve products or services for other customers; or
- authorize its service providers to use your User Content to train or improve their generalized models.
Anonymous Platform Improvement (Personal Plan)
On the Personal plan, you also allow Elytron to use Anonymous Platform Data to train, tune, evaluate, and improve Elytron's platform, including its pipelines, annotation systems, and AI agents.
"Anonymous Platform Data" means aggregated or statistical information derived from the operation of the Service, such as success and failure rates, processing times, annotation and quality metrics, which tools were used, error categories, and feedback ratings. Anonymous Platform Data does not contain, and cannot reasonably be used to reconstruct, your sequences, prompts, conversation text, or Outputs, and does not identify you or your organization. Elytron may retain Anonymous Platform Data after you delete your content or close your account, to the extent permitted by applicable law.
Professional Plan: No Training or Elytron R&D Use
If your account is on an active paid Professional plan, Elytron will not use your User Content, or Anonymous Platform Data derived from it, to train, tune, evaluate, benchmark, or improve machine-learning or artificial-intelligence models, or to conduct Elytron scientific or product research and development, except within your own request solely to provide the Service to you. This applies to content submitted while that plan is active ("Professional User Content").
Other Permitted Uses
The restrictions in this Section do not prevent Elytron from using (a) account and billing information; (b) security, reliability, performance, and usage telemetry that does not contain User Content; (c) feedback that you separately and intentionally submit for product improvement, provided that submitting feedback does not authorize use of your other User Content; or (d) information that you direct Elytron to publish or expressly authorize in writing for a broader use. Elytron may retain general know-how gained from operating the Service, provided it does not contain or reproduce User Content and Elytron does not represent that it owns your original User Content solely because it was submitted to the Service.
All plans include the protections stated above. If you require additional restrictions such as isolated processing, custom retention, data residency, or expanded contractual confidentiality, those restrictions must be stated in a separate written enterprise or data agreement signed by Elytron.
6. No Confidential Relationship by Default
Unless you and Elytron have entered into a separate written confidentiality agreement, enterprise agreement, or other agreement expressly providing confidentiality obligations, use of the standard ElyChat Service does not create a confidential, fiduciary, attorney-client, physician-patient, research-collaboration, joint-venture, partnership, or similar relationship.
You should not upload information requiring protections beyond those expressly provided in these Terms and the Privacy Policy.
7. Outputs
“Outputs” means responses, annotations, summaries, classifications, predictions, searches, alignments, inferred functions, candidate genes, pathways, taxonomic assignments, scores, citations, interpretations, recommendations, or other content generated or presented by the Service.
Subject to these Terms and applicable law, you may use Outputs generated for you. Elytron retains all rights in the Service, its software, models, algorithms, pipelines, architecture, databases, workflows, prompts, methods, and underlying technology.
Outputs may not be unique. Other users may receive identical or similar outputs. Elytron makes no representation that an Output is novel, protectable, non-infringing, patentable, commercially exploitable, or suitable for any particular purpose.
8. IMPORTANT: Research Tool; Outputs May Be Wrong
ELYCHAT IS PROVIDED AS A RESEARCH AND INFORMATION TOOL. THE SERVICE AND ALL OUTPUTS MAY CONTAIN ERRORS, OMISSIONS, FALSE POSITIVES, FALSE NEGATIVES, INCORRECT ANNOTATIONS, INCORRECT TAXONOMIC OR FUNCTIONAL ASSIGNMENTS, SOFTWARE OR DATABASE ERRORS, MODEL HALLUCINATIONS, OUTDATED INFORMATION, INCOMPLETE INFORMATION, OR OTHER INACCURACIES.
Computational predictions do not establish biological function, phenotype, safety, efficacy, pathogenicity, virulence, antimicrobial resistance, metabolic activity, regulatory status, freedom to operate, novelty, or experimental validity.
YOU ARE SOLELY RESPONSIBLE FOR INDEPENDENTLY REVIEWING, VERIFYING, AND VALIDATING ALL OUTPUTS BEFORE RELYING ON THEM. Appropriate verification may include review by qualified personnel, inspection of source data and references, use of independent software, and laboratory or field validation as appropriate.
ANY USE OF OR RELIANCE ON THE SERVICE OR OUTPUTS IS AT YOUR SOLE RISK. You are solely responsible for decisions, experiments, research, publications, regulatory submissions, product development, commercial activities, laboratory work, field work, biosafety decisions, intellectual-property decisions, and other actions taken based on or informed by the Service or Outputs.
9. No Professional, Regulatory, Medical, or Safety Advice
ElyChat does not provide medical, clinical, diagnostic, veterinary, legal, patent, regulatory, biosafety, biosecurity, laboratory-safety, or other professional advice.
You must not rely on ElyChat as the sole basis for decisions that could affect human or animal health, environmental safety, regulatory compliance, biosafety containment, laboratory safety, product release, or other high-consequence activities.
10. Acceptable Use
You must comply with the ElyChat Acceptable Use Policy.
Without limiting that policy, you may not use ElyChat to:
- violate law or third-party rights;
- upload human sequence data;
- gain unauthorized access to systems or data;
- facilitate biological harm or intentionally increase the ability of a biological agent to cause disease or evade detection, treatment, containment, or control;
- design, develop, optimize, or operationalize biological agents, toxins, or systems for harmful purposes;
- misrepresent Outputs as experimentally validated when they are not; or
- interfere with, reverse engineer, scrape, overload, or circumvent technical restrictions of the Service, except to the extent such restriction is prohibited by law.
11. Third-Party Services and Data Sources
The Service may rely on or interact with third-party software, models, databases, publications, APIs, cloud infrastructure, or other resources. Third-party content may be inaccurate, unavailable, incomplete, changed, or subject to separate terms.
Elytron does not control and is not responsible for third-party services or content. References or links do not constitute endorsement.
12. Service Changes, Availability, and Data Loss
Subject to Section 13 below and applicable law, we may modify, update, suspend, discontinue, limit, or change any part of the Service, including features, models, databases, pipelines, plans, usage limits, and pricing.
We do not guarantee uninterrupted availability, processing time, storage duration, preservation of files, reproducibility across versions, or compatibility with any particular data format or workflow.
You are responsible for maintaining independent backups of all User Content and Outputs that you wish to preserve. ElyChat is not a backup or archival service.
13. Plans, Usage Limits, Fees, and Subscriptions
ElyChat may offer free, paid, promotional, trial, pilot, enterprise, or other plans. The plan descriptions, prices, billing periods, included features, usage allowances, and other limits then in effect will be shown on our pricing page, during purchase, in your account, or in an applicable order form. A separate written agreement signed by Elytron controls if it expressly conflicts with these Terms.
As of the Last Updated date:
- Personal is a self-service base plan that includes capacity for up to 5 active genomes and essential AI analysis capacity.
- Professional is a paid plan that includes capacity for up to 20 active genomes, higher AI analysis capacity, priority support, and the Professional User Content protections stated in Section 5.
These descriptions state current plan parameters, not permanent commitments. In particular, offering Personal without a current subscription fee does not guarantee that Personal, any feature, any usage allowance, or any price will remain available or free for any period.
Plan limits may include active genomes, uploads, file size, storage, processing jobs, tokens, credits, messages, queries, model access, compute consumption, rate limits, users, retention, support, or other technical or commercial measures. Limits may be measured over different periods, may not roll over, and may vary by feature or workload. “Up to” identifies a maximum cap and is not a guarantee that all capacity will be continuously available. We may enforce limits by restricting uploads or processing, reducing throughput, suspending a feature, requiring deletion or archival of content, or requiring a plan change. We will not impose an overage charge unless the charge was disclosed and you authorized it.
We may add, remove, rename, replace, or discontinue plans and may increase or decrease prices, features, included capacity, eligibility, and usage limits. Changes to an unpaid plan may take effect when posted or on the date stated in a notice. When reasonably practicable, we will provide advance notice of a material reduction to an unpaid plan, but operational, legal, safety, security, or abuse-prevention changes may take effect immediately.
We will not begin charging you for an unpaid plan without presenting the applicable price and obtaining the payment authorization or other affirmative agreement required by law. If you do not accept a new paid offering, we may limit, downgrade, suspend, or discontinue the affected unpaid access.
For a paid subscription, the applicable fees, billing period, renewal terms, and cancellation process will be presented at purchase or in an order form. Unless otherwise stated, a change to the recurring subscription price will not apply during a billing period already paid and will apply no earlier than a subsequent renewal after advance notice. You may cancel before that renewal to avoid the new recurring price. Features and limits may still change during a paid term when reasonably necessary for legal, safety, security, abuse-prevention, third-party dependency, or service-operability reasons, subject to applicable law and any express written commitment.
If your plan expires, is cancelled, is downgraded, or is discontinued, content or functionality exceeding the new plan limits may become read-only, unavailable, or subject to deletion under our retention practices. You are responsible for exporting and maintaining independent backups of User Content and Outputs you wish to preserve. A plan change does not retroactively remove the Professional User Content protections in Section 5 from content submitted while an active paid Professional plan applied.
Unless required otherwise by law or expressly stated, fees are non-refundable once incurred.
Taxes may apply. You are responsible for applicable taxes other than taxes based on Elytron’s net income.
14. Intellectual Property
Elytron and its licensors own all rights, title, and interest in and to the Service and its underlying technology, including software, source code, interfaces, designs, models, pipelines, databases, methods, documentation, trademarks, and improvements.
Except for the limited right to use the Service under these Terms, no rights are granted to you by implication, estoppel, or otherwise.
If you provide suggestions, ideas, bug reports, feature requests, or other feedback, you grant Elytron a perpetual, irrevocable, worldwide, royalty-free right to use and exploit that feedback without restriction or compensation.
15. Suspension and Termination
You may stop using the Service at any time.
Elytron may suspend or terminate access to all or part of the Service if we reasonably believe you have violated these Terms, created legal or security risk, failed to pay applicable fees, abused the Service, or if continued provision is no longer commercially or technically practicable.
Sections that by their nature should survive termination will survive, including provisions concerning licenses already granted, derived information, intellectual property, disclaimers, limitations of liability, indemnification, dispute resolution, and miscellaneous terms.
16. DISCLAIMER OF WARRANTIES
TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, THE SERVICE, USER-ACCESSIBLE DATABASES, PIPELINES, MODELS, THIRD-PARTY CONTENT, AND OUTPUTS ARE PROVIDED “AS IS” AND “AS AVAILABLE,” WITH ALL FAULTS AND WITHOUT WARRANTIES OF ANY KIND.
ELYTRON DISCLAIMS ALL EXPRESS, IMPLIED, STATUTORY, AND OTHER WARRANTIES, INCLUDING WARRANTIES OF ACCURACY, COMPLETENESS, RELIABILITY, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, NON-INFRINGEMENT, QUIET ENJOYMENT, DATA INTEGRITY, AVAILABILITY, SECURITY, REPRODUCIBILITY, SCIENTIFIC VALIDITY, AND RESULTS.
ELYTRON DOES NOT WARRANT THAT THE SERVICE OR ANY OUTPUT WILL BE ERROR-FREE, COMPLETE, CURRENT, SECURE, UNINTERRUPTED, EXPERIMENTALLY VALIDATED, OR SUITABLE FOR RESEARCH, COMMERCIAL, REGULATORY, LABORATORY, FIELD, OR OTHER USE.
No oral or written information provided by Elytron creates a warranty unless expressly stated in a signed written agreement.
Some jurisdictions do not allow certain warranty exclusions, so some exclusions may not apply to you.
17. LIMITATION OF LIABILITY
TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, ELYTRON BIOTECH CORPORATION AND ITS AFFILIATES, OFFICERS, DIRECTORS, EMPLOYEES, CONTRACTORS, LICENSORS, SERVICE PROVIDERS, AND AGENTS WILL NOT BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, PUNITIVE, OR CONSEQUENTIAL DAMAGES, OR FOR ANY LOSS OF PROFITS, REVENUE, BUSINESS, OPPORTUNITY, GOODWILL, DATA, RESEARCH MATERIAL, EXPERIMENTS, PRODUCTIVITY, OR ANTICIPATED SAVINGS, ARISING OUT OF OR RELATED TO THE SERVICE OR THESE TERMS, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
Without limiting the foregoing, Elytron will not be liable for losses or damages resulting from:
- inaccurate, incomplete, misleading, hallucinated, or erroneous Outputs;
- false-positive or false-negative biological predictions;
- incorrect gene, protein, pathway, taxonomic, phenotype, resistance, virulence, or functional annotations;
- reliance on an Output in laboratory, field, regulatory, scientific, intellectual-property, investment, manufacturing, product-development, or commercial decisions;
- contamination, failed experiments, lost samples, biological or environmental effects, or biosafety incidents;
- third-party databases, models, publications, software, infrastructure, or services;
- unauthorized access, deletion, corruption, or loss of User Content where liability cannot lawfully be excluded only to the extent required by law; or
- your failure to independently verify an Output or maintain backups.
TO THE MAXIMUM EXTENT PERMITTED BY LAW, ELYTRON’S TOTAL AGGREGATE LIABILITY ARISING OUT OF OR RELATING TO THE SERVICE OR THESE TERMS WILL NOT EXCEED THE GREATER OF (A) THE AMOUNT YOU PAID TO ELYTRON FOR THE SERVICE DURING THE TWELVE MONTHS IMMEDIATELY PRECEDING THE EVENT GIVING RISE TO THE CLAIM OR (B) US$100.
The limitations in this section apply regardless of the theory of liability and even if a remedy fails of its essential purpose. They do not limit liability that cannot lawfully be limited or excluded.
18. Indemnification
To the extent permitted by law, you will defend, indemnify, and hold harmless Elytron and its affiliates, officers, directors, employees, contractors, licensors, service providers, and agents from and against claims, liabilities, damages, judgments, losses, costs, and expenses, including reasonable attorneys’ fees, arising from or related to:
- your User Content;
- your use or misuse of the Service or Outputs;
- your experiments, products, publications, regulatory submissions, commercial activities, or other actions based on the Service;
- your violation of these Terms or the Acceptable Use Policy;
- your violation of applicable law; or
- your infringement or violation of another person’s rights.
This obligation does not apply to the extent a claim results from conduct for which indemnification may not lawfully be required.
19. Privacy
Our collection and use of personal information is described in the ElyChat Privacy Policy.
Sequence data submitted to ElyChat is limited by these Terms to non-human bacterial and fungal data. Account information, communications, device information, and usage information may nevertheless constitute personal information and are handled as described in the Privacy Policy.
20. Electronic Communications
You agree that Elytron may provide notices electronically, including by email, through the Service, or by posting notices on the Service. Transactional and service communications are part of the Service and may not always be optional.
Marketing communications, where used, will be handled in accordance with applicable law and available opt-out mechanisms.
21. Changes to These Terms
We may update these Terms from time to time. We will post the updated Terms and revise the “Last Updated” date. Where required by law, we will provide additional notice or obtain renewed consent for material changes.
Your continued use of the Service after an updated version becomes effective constitutes acceptance to the extent permitted by law. If you do not agree to an update, you must stop using the Service.
22. Governing Law
Except where mandatory law provides otherwise, these Terms are governed by the laws of the State of Delaware, United States, without regard to conflict-of-laws principles.
23. Binding Arbitration and Class Action Waiver
PLEASE READ THIS SECTION CAREFULLY. IT AFFECTS YOUR LEGAL RIGHTS.
Except for claims that qualify for small-claims court or requests for temporary or preliminary injunctive relief concerning unauthorized access, misuse, or intellectual property, any dispute arising out of or relating to these Terms or the Service will be resolved by binding individual arbitration under the Federal Arbitration Act.
Before commencing arbitration, the complaining party must send written notice describing the dispute and requested relief to elychat@elytronbiotech.com and allow at least 30 days for an informal attempt to resolve the dispute.
If unresolved, arbitration will be administered by the American Arbitration Association under the applicable AAA rules. The arbitration may be conducted remotely unless the arbitrator determines otherwise. Each party may seek remedies available under applicable law, subject to these Terms.
DISPUTES MUST BE BROUGHT ON AN INDIVIDUAL BASIS. TO THE MAXIMUM EXTENT PERMITTED BY LAW, YOU AND ELYTRON WAIVE ANY RIGHT TO PARTICIPATE IN A CLASS, COLLECTIVE, CONSOLIDATED, OR REPRESENTATIVE ACTION OR ARBITRATION.
You may opt out of this arbitration provision by emailing elychat@elytronbiotech.com within 30 days after you first accept these Terms, with the subject line “Arbitration Opt-Out,” and including the name and email address associated with your account.
If this arbitration provision is found unenforceable for a particular claim, that claim will be brought exclusively in the state or federal courts located in New Castle County, Delaware, unless applicable law requires otherwise.
Nothing in this section limits rights or remedies that cannot lawfully be waived.
24. Export, Sanctions, and Legal Compliance
You may not use or access the Service in violation of U.S. export-control, sanctions, or other applicable laws. You represent that you are not prohibited from receiving the Service under applicable law.
25. Miscellaneous
These Terms and the documents incorporated by reference constitute the entire agreement governing the standard Service unless you and Elytron have a separate signed agreement that expressly supersedes them.
If a provision is unenforceable, it will be enforced to the maximum extent permitted and the remaining provisions will remain in effect.
Failure to enforce a provision is not a waiver. You may not assign these Terms without Elytron’s prior written consent. Elytron may assign these Terms in connection with a merger, acquisition, financing, reorganization, sale of assets, corporate restructuring, or by operation of law.
Headings are for convenience only.
26. Contact
Elytron Biotech Corporation
251 Little Falls Drive
Wilmington, New Castle County, Delaware 19808
United States
Email: elychat@elytronbiotech.com